Displaying results 1-10 of 1135 for "WA 0859 3970 0884 Harga Membuat Interior Rumah Lantai 2 Ukuran 4x6 Di Serengan Surakarta"

• ASBMB Today Article
  5 ways the Biden administration may help stem the loss of international students
  Feb. 10, 2021
  

  Over the past four years, the Trump administration made it increasingly difficult for students from other countries to study in the United States. President Joe Biden’s election signals a new day for international education.
• ASBMB Today Article
  SARS-CoV-2 variants remodel cellular landscapes
  Oct. 19, 2023
  

  Scientists find that the ancestral strain of SARS-CoV-2 and the omicron and delta variants trigger varying immunological responses.
• Meetings and events
  Insight on novel roles and regulation of phosphoinositide lipids
  

  Dec. 2, 2020
• ASBMB Today Article
  A great escape — how SARS-CoV-2 evades our defenses
  May 25, 2023
  

  Preliminary evidence shows that SARS-CoV-2 uses molecular mimicry, in which one of its proteins acts like a protein in our immune system.
• ASBMB Today Article
  Annual meeting workshops: Part 2
  Jan. 21, 2020
  

  Topics include lab management, moving from academia to industry, and teaching biology with augmented reality and Lego bricks.
• Meetings and events
  Lipids in viral infection: part 2
  

  Oct. 14, 2020
• Meetings and events
  Addressing imposter fears at any career stage
  

  Sept. 24 | 2 p.m. EDT
• ASBMB Today Article
  Essential process for SARS-CoV-2 viral replication visualized
  July 2, 2023
  

  High-resolution images provide clarity into how viral proteins are separated by a protease, an important step during virus replication that is targeted by an approved COVID-19 drug.
• ASBMB Today Article
  Acylcarnitines, a warning signal for Type 2 diabetes
  March 15, 2022
  

  One of the lipid classes elevated in plasma with diabetic dyslipidemia, acylcarnitines function in transport and signaling.
• ASBMB Today Article
  Pointers for an industry career: part 2
  Sept. 1, 2016
  

  This is the second in a three-part series of interviews with Kenneth I. Maynard of Takeda Pharmaceuticals International Inc. about what it takes to launch a career in industry.